Tag: Leo
Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. With several positive studies in hand, including a recent phase 3 trial pitting the candidate against the current standard-of-care, Leo says its delgocitinib has growth driver potential. Now, the drugmaker […]
Eczema is one of the main skin conditions that can develop over time. Also, if you sometimes have itchy and red spots on your hands, it’s probably eczema. Eczema is often called atopic dermatitis, where atopic refers to allergy. Also, any eczema may have persistent symptoms such as dry or scaly skin, redness or itching. […]
The Eczema Therapeutics Market research report presents a complete and concise global market study. It offers quantitative and qualitative information on the entire industry structure. This Eczema Therapeutics research report delivers an overview of the market based on the segmentation, which helps the client easily understand the need. The markets are expected to depict a […]